Evidence map›Paper›PMID 33859316›Full record

ArticleScientific reports2021

One-pot synthesis of zinc oxide nanoparticles via chemical precipitation for bromophenol blue adsorption and the antifungal activity against filamentous fungi.

Kovo G Akpomie, Soumya Ghosh, Marieka Gryzenhout, Jeanet Conradie

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. ZnS-CuS-CuRSC advances · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Sustainable antifungal potential of ZnO and MoSWorld journal of microbiology & biotechnology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Synthesis of zinc oxide nanoparticles usingFrontiers in microbiology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kovo G AkpomieDepartment of Chemistry, University of the Free State, Bloemfontein, South Africa. kovo.akpomie@unn.edu.ng.
Soumya GhoshDepartment of Genetics, University of the Free State, Bloemfontein, ZA9300, South Africa.
Marieka GryzenhoutDepartment of Genetics, University of the Free State, Bloemfontein, ZA9300, South Africa.
Jeanet ConradieDepartment of Chemistry, University of the Free State, Bloemfontein, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, zinc oxide nanoparticles (ZnONPs) were prepared via a facile one-pot chemical precipitation approach and applied in the adsorption of bromophenol blue (BRB) and as antifungal agents against the filamentous fungi and plant pathogens; Alternaria alternata CGJM3078, Alternaria alternata CGJM3006 and Fusarium verticilliodes CGJM3823. The ZnONPs were characterized by the UV-Vis, FTIR, XRD, TGA, BET, SEM, TEM, and EDX techniques, which showed efficient synthesis. The characteristics ZnO UV-Vis absorption band was observed at 375 nm, while the XRD showed an average ZnONPs crystalline size of 47.2 nm. The SEM and TEM images showed an irregular shaped and aggregated porous structure of 65.3 nm average-sized ZnONPs. The TGA showed 22.9% weight loss at 800 °C indicating the high thermal stability of ZnONPs, while BET analysis revealed a surface area, pore volume and pore diameter of 9.259 m

Indexed as

Chemical PrecipitationNanoparticlesAdsorptionBromphenol BlueDrug Resistance, FungalFungiZinc OxideBromphenol BlueZinc Oxide

Identifiers

PMID33859316
PMCPMC8050082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.